Vitruvian Shield RESEARCH
The full-stack SaaS platform for mid-market contract research organizations and academic medical centers. Trial management, data capture, patient-reported outcomes, remote monitoring. Swiss-built, Azure-native, biosignal-native from day one.
Why RESEARCH is different
Three structural advantages over the incumbent CRO stack.
Continuous biosignal ingestion
Biosignal ingestion from 1 Hz to 256 Hz is native, not a custom engineering project. Heart rate, ECG, EEG, accelerometry, and respiration route into a unified data model without integration work.
Pre-validated regulatory architecture
ALCOA++, HIPAA design alignment, and GDPR compliant from day one. ISO 13485, ISO 27001, 21 CFR Part 11, and EU MDR pathways in progress under our ongoing certification programme.
AI-assisted CRF design
AI-assisted questionnaire and CRF builder in early access Q2 2026 for design partners. Describe the instrument you need in plain language; the builder drafts structure, validation rules, and skip logic.
Deployment timeline
Comparison against published guidance and public case studies for incumbent DCT platforms.
- Vitruvian Shield RESEARCH2-3 weeks
- Medable8-12 weeks
- Veeva Vault CTMS4-5 months
- Medidata Rave6 months
Two to three week deployment applies to the currently generally-available RESEARCH configuration: organizational dashboard, research dashboard, questionnaire-based ePRO, and remote patient monitoring with supported devices (Analog Devices VSM Watch, Dexcom G7 via Thryve integration, Corsano). Studies requiring the full six-module configuration follow extended timelines during the 2026 platform expansion programme.
Transparent, published pricing
Transparent pricing is a deliberate positioning choice. Most incumbents do not publish.
Annual license
CHF 15,000 — 75,000
Tiered by organization size and module configuration. Covers platform access, unlimited users, and standard support.
Per patient, per study
CHF 240 — 380
Scales with study enrollment. Covers RPM device data ingestion, ePRO scheduling, storage, and audit-trail evidence.
Indicative ranges. Final pricing depends on study scope, device mix, and support level. Contact sales for a tailored quote.
Who RESEARCH is built for
Teams where the bottleneck is deployment speed and cost per study, not enterprise procurement.
Mid-tier CROs
Contract research organizations running 5 to 50 concurrent studies that need a modern, API-first platform without enterprise lock-in.
Academic medical centers
University hospitals and academic research networks running investigator-initiated trials and observational studies.
Investigator-initiated studies
Individual principal investigators funded through grants (Innosuisse, ANI, NIH, Horizon Europe) who need a turnkey platform.
Hospital research units
In-house research units at hospital networks that want to standardize data capture across the institution.
Ready to Modernize Your Clinical Trials?
Join leading sponsors, CROs, and research sites using Vitruvian Shield to run faster, smarter, and more compliant trials.
Or contact our team for a personalized walkthrough.